Exploring Duodenal Biopsies as a Biomarker of Pancreatic Cancer
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 17-000807
Sponsor Protocol Number: 17-000807
About this study
To determine whether the microbiome, metagenome and metabolome of the tissue of the second portion of duodenum of patients with pancreatic cancer are different from that of patients with benign conditions not affecting the pancreas.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Subject and Control Inclusion Criteria
- Adults aged 18 and older
- Patients scheduled to undergo an endoscopy.
- Patients with indications for endoscopy due to known of suspected Pancreatic Cancer but no other GI tract cancer, polyps and who are scheduled for endoscopy as part of their medical evaluation.
Subject and Control Exclusion Criteria
- Individuals who do not comprehend English (i.e. participants must be able to read and sign a consent form without the assistance of an interpreter.)
- Individuals who are unable to sign consent (e.g., mentally challenged, those declared legally incompetent)
- Individuals regarded as belonging to a vulnerable population (e.g., prisoners)
- Patients diagnosed with Helicobacter pylori infection
- Patients with suspected GI tract cancer other than pancreatic cancer
- Antibiotic use within the past 3 months
- Any surgical procedure on the GI tract
- Age <18 or vulnerable adults
- Presence of bleeding disorders
- Use of anti-coagulants
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Mark Truty, M.D., M.S. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available